{"symbol":"BMY","fiscalQuarter":"Q3-2018","reportDate":"2018-10-25","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q3-2018","postBrief":{"headline":"Bristol Myers Squibb Beats on EPS, Stock Up 0.78%","keyNumbers":[{"metric":"EPS","actual":"$1.09","expected":"N/A","surprise":"+14.96%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on delivering value through our innovative pipeline."],"summary":"Management expressed satisfaction with the EPS results, highlighting the strength of their product pipeline. They emphasized their commitment to driving future growth."},"guidanceChanges":{"summary":"No guidance updates were provided during the call.","changes":[]},"whatItMeans":"Bristol Myers Squibb's earnings report shows a strong performance in EPS, exceeding expectations. The stock reacted positively, increasing by 0.78%. This suggests investor confidence in the company's current trajectory, although no guidance was offered for future performance.","metaDescription":"Bristol Myers Squibb (BMY) Q3 2018 earnings: EPS beat by 14.96%. Stock up 0.78%. Full breakdown."}}